PAR
Click for more information
3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-247

  1. Denial
    9,737 Posts.
    lightbulb Created with Sketch. 1234
    clock Created with Sketch.
    14/04/23
    12:46
    Post #: 67276094
    Yes this will be the fundamental starting point for PAR and the FDA

    Humira records ongoing SAE with their dosage schedule. FDA will not want to see this for Zilosul given the OA population size


    PAR Price at posting: $1.12 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢ 		Change
-0.010(3.23%) 		Mkt cap ! $108.4M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $113.2K 367.1K

Buyers (Bids)

No. Vol. Price($)
2 18081 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 11136 4
View Market Depth
Last trade - 12.59pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.